Practice Guideline Recommendations Summary: Disease-modifying Therapies for Adults with Multiple Sclerosis

Guideline Detail

April 2018

Recommendations from current practice guideline. Endorsed by the Multiple Sclerosis Association of America and the National Multiple Sclerosis Society. Companion to "Systematic Review Summary: Disease-modifying Therapies for Adults with Multiple Sclerosis" (April 2018).

Questions?

Email guidelines@aan.com

Call (800) 879-1960 or (612) 928-6000 (international)

Top

Footer